KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235 | -39.0% | 16,904 | +0.9% | 0.00% | – |
| Q2 2023 | $385 | -37.8% | 16,756 | -19.8% | 0.00% | -100.0% |
| Q1 2023 | $619 | -8.3% | 20,891 | -22.7% | 0.00% | 0.0% |
| Q4 2022 | $675 | -99.9% | 27,038 | +0.0% | 0.00% | 0.0% |
| Q3 2022 | $588,000 | +10.7% | 27,031 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $531,000 | -53.5% | 26,953 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $1,142,000 | -26.6% | 26,996 | +10.2% | 0.00% | -50.0% |
| Q4 2021 | $1,555,000 | +16.9% | 24,493 | +8.2% | 0.00% | +100.0% |
| Q3 2021 | $1,330,000 | +10.2% | 22,636 | -9.0% | 0.00% | 0.0% |
| Q2 2021 | $1,207,000 | +223.6% | 24,877 | +159.1% | 0.00% | – |
| Q1 2021 | $373,000 | -23.9% | 9,600 | +21.5% | 0.00% | -100.0% |
| Q4 2020 | $490,000 | – | 7,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |